A carregar...
Publicação
Synergy valuation in the Pfizer - seagen acquisition - influencing factors on acquisition premiums in R & D intensive industries for Us acquirers
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.89 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This thesis examines the Pfizer-Seagen acquisition, a pivotal deal in the pharmaceutical
industry. It starts with a literature review on valuation methods and further analyses the strategic
motivations and financial implications of mergers and acquisitions in the industry. The thesis
assesses both companies' market positions, strategies, and financial health, to perform two
comprehensive standalone valuations. It also conducts a combined valuation to explore
potential synergies and economically feasible offer prices, comparing these to Pfizer's
announced offer. Additionally, the thesis analyses the factors influencing premiums in M&As
and stock reactions post-announcement in R&D intensive industries.
Descrição
Palavras-chave
Merger and acquisitions Valuation Pharmaceutical industry Pfizer Seagen